Curis | CRIS - Nettoeinkommen

Aktienkurs
0.64
Täglich Wechseln
0.02 3.10%
Monatlich
-25.50%
Jährlich
-50.46%
Q2 Prognose
0.49




Nettoeinkommen Veränderung Datum
Alaunos Therapeutics USD -1.16M 108K 2025-09
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bayer EUR -3.76B 2.79B 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
CSL USD 401M 96.5M 2025-12
Curis USD 19.36M 31.16M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Incyte USD 299.28M 124.89M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Takeda JPY 103.64B 115.44B 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12
Verastem USD -32.92M 24.66M 2025-12
Xoma USD -17.24M 33.23M 2024-09